Literature DB >> 24940307

Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India.

P Mithra1, B Unnikrishnan1, T Rekha1, K Nithin1, K Mohan1, V Kulkarni1, V Kulkarni1, D Agarwal1.   

Abstract

BACKGROUND: Anaemia is highly prevalent among pregnant women and iron deficiency is the most important cause. Like many other countries, India has policies to give pregnant women iron supplements. Non-compliance is one important challenging factor in combating anaemia.
OBJECTIVE: To estimate the compliance for IFA tablets among pregnant women and to study the social factors influencing it.
METHODOLOGY: This study included 190 pregnant women seeking ante-natal care in tertiary health centres in the Mangalore city in south India. After Institutional Ethics Committee (IEC) approval, data was collected by personal interview. Missing >2 doses consecutively was considered non-compliance. The data was analyzed using SPSS (Statistical Package for Social Sciences) version 11.5.
RESULTS: The mean age of the study population was 25.8 years (SD: 4.1). Most of the subjects consumed mixed diet and 72.1% belonged to lower socioeconomic status. Overall, compliance with IFA tablets was 64.7%. Compliance increased with the increase in age, birth order and single daily dose. Forgetfulness and both perceived as well as experienced side effects of IFA therapy were the important factors for non-compliance.
CONCLUSION: There was a moderate level of compliance towards IFA tablets with key social and demographic factors playing an important role.

Entities:  

Keywords:  Compliance; IFA tablets; demographic; folic Acid; iron; social

Mesh:

Substances:

Year:  2013        PMID: 24940307      PMCID: PMC4056486          DOI: 10.4314/ahs.v13i4.3

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  6 in total

1.  Kuppuswamy's socioeconomic status scale-updating for 2007.

Authors:  N Kumar; C Shekhar; P Kumar; A S Kundu
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

Review 2.  Folic acid: influence on the outcome of pregnancy.

Authors:  T O Scholl; W G Johnson
Journal:  Am J Clin Nutr       Date:  2000-05       Impact factor: 7.045

3.  Determinants of compliance with iron supplementation among pregnant women in Senegal.

Authors:  Binetou C Seck; Robert T Jackson
Journal:  Public Health Nutr       Date:  2007-09-03       Impact factor: 4.022

Review 4.  Determinants of compliance with iron supplementation: supplies, side effects, or psychology?

Authors:  R Galloway; J McGuire
Journal:  Soc Sci Med       Date:  1994-08       Impact factor: 4.634

Review 5.  Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy.

Authors:  Juan Pablo Peña-Rosas; Fernando E Viteri
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

6.  Women's perceptions of iron deficiency and anemia prevention and control in eight developing countries.

Authors:  Rae Galloway; Erin Dusch; Leslie Elder; Endang Achadi; Ruben Grajeda; Elena Hurtado; Mike Favin; Shubhada Kanani; Julie Marsaban; Nicolas Meda; K Mona Moore; Linda Morison; Neena Raina; Jolly Rajaratnam; Javier Rodriquez; Chitra Stephen
Journal:  Soc Sci Med       Date:  2002-08       Impact factor: 4.634

  6 in total
  26 in total

1.  Non communicable diseases and infections refuse to go away despite current knowledge and scientific advances.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  Infections and non-communicable diseases that just refuse to go away.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

3.  How Non Consumers Differ from Consumers: A Qualitative Approach to Synthesize the Attributes of Iron Folic Acid End Users.

Authors:  Surya Bali; Ankur Joshi; Sharad Tiwari; Daneshwar Singh; Viswanath Arutagi; Saket Kale; DInesh Kumar Pal
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  The relationship between maternal self-efficacy, compliance and outcome in a trial of vitamin D supplementation in pregnancy.

Authors:  M Barker; S D'Angelo; G Ntani; W Lawrence; J Baird; M Jarman; C Vogel; H Inskip; C Cooper; N C Harvey
Journal:  Osteoporos Int       Date:  2016-08-22       Impact factor: 4.507

5.  Factors Influencing Antenatal Haematinics Prescription Behaviour of Physicians in Calabar, Nigeria.

Authors:  Ubong Akpan; Thomas Agan; Emmanuel Monjok; Chinedu Okpara; Saturday Etuk
Journal:  Open Access Maced J Med Sci       Date:  2017-03-20

6.  Maternal anemia and underweight as determinants of pregnancy outcomes: cohort study in eastern rural Maharashtra, India.

Authors:  Archana Patel; Amber Abhijeet Prakash; Prabir Kumar Das; Swarnim Gupta; Yamini Vinod Pusdekar; Patricia L Hibberd
Journal:  BMJ Open       Date:  2018-08-08       Impact factor: 2.692

7.  The Influence of Antenatal Oral Iron and Folic Acid Side Effects on Supplementation Duration in Low-Resource Rural Kenya: A Cross-Sectional Study.

Authors:  Shadrack Oiye; Margaret Juma; Silvenus Konyole; Fatuma Adan
Journal:  J Pregnancy       Date:  2020-05-11

8.  Compliance with iron folic acid (IFA) tablets and associated factors among pregnant women attending ante-natal care clinic at Sub District Hospital, Ballabgarh.

Authors:  Trideep J Deori; Gomathi Ramaswamy; Abhishek Jaiswal; Vignesh Loganathan; Rakesh Kumar; Reeta Mahey; Kapil Yadav; Shashi Kant
Journal:  J Family Med Prim Care       Date:  2021-05-31

9.  Compliance with Iron-Folate Supplement and Associated Factors among Antenatal Care Attendant Mothers in Misha District, South Ethiopia: Community Based Cross-Sectional Study.

Authors:  Abinet Arega Sadore; Lakew Abebe Gebretsadik; Mamusha Aman Hussen
Journal:  J Environ Public Health       Date:  2015-12-29

10.  Routine Iron Supplementation and Anaemia by Third Trimester in a Nigerian Hospital.

Authors:  Abiodun I Adanikin; Jacob O Awoleke; Babatunde A Olofinbiyi; Pipeloluwa O Adanikin; Omobolanle R Ogundare
Journal:  Ethiop J Health Sci       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.